Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
   
Ask the Experts About

Choosing Your MedsChoosing Your Meds
           
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


Considering Treatment
May 30, 2004

I have been positive for 2 1/2 years. My recent lab work shows my CD4 just above 400 and my t-cells at 21,000. This is the lowest/highest they have ever been. Should I be considering treatment?

Response from Dr. Young

Thanks for your question.

Your recent CD4 cell count suggests to me that you might be nearing a range where starting therapy should be considered-- but not yet. Current recommendations for asymptomatic persons is to consider (not mandatory) starting therapy when CD4s are below 350. When my patient's numbers approach this, I make sure that we get follow up lab testing in 2-4 months. With a average or slighly below average viral load, your risk of having rapid progression, is for now, pretty low; so waiting until your next test is unlikely to cause any problems.

Good luck and thanks for reading. BY



Previous
Oral Cavities and HIV
Next
morning versus afternoon results

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement